Chemed (NYSE:CHE) Price Target Cut to $500.00 by Analysts at Oppenheimer

Chemed (NYSE:CHE) had its price objective cut by Oppenheimer from $580.00 to $500.00 in a report issued on Friday,Benzinga reports. They currently have an outperform rating on the stock.

Other research analysts have also issued research reports about the stock. Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a research report on Thursday, October 30th. Royal Bank Of Canada restated a “sector perform” rating and set a $422.00 target price (down from $572.00) on shares of Chemed in a research note on Friday. Jefferies Financial Group downgraded Chemed from a “buy” rating to a “hold” rating in a research report on Thursday, January 22nd. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, January 21st. Two analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $498.00.

Chemed Price Performance

Shares of CHE stock traded up $13.51 on Friday, hitting $410.14. The company’s stock had a trading volume of 407,825 shares, compared to its average volume of 205,571. Chemed has a fifty-two week low of $385.00 and a fifty-two week high of $623.60. The firm’s fifty day moving average price is $446.06 and its 200-day moving average price is $443.89. The stock has a market capitalization of $5.81 billion, a price-to-earnings ratio of 22.33, a P/E/G ratio of 1.93 and a beta of 0.44.

Chemed (NYSE:CHE) last released its quarterly earnings results on Wednesday, February 25th. The company reported $6.42 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.02 by ($0.60). Chemed had a return on equity of 24.70% and a net margin of 10.48%.The company had revenue of $639.34 million for the quarter, compared to the consensus estimate of $659.09 million. During the same quarter last year, the company posted $6.83 EPS. The business’s revenue was down .1% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. Analysts predict that Chemed will post 21.43 EPS for the current fiscal year.

Chemed Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, March 13th. Stockholders of record on Monday, February 23rd will be paid a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend is Monday, February 23rd. Chemed’s dividend payout ratio is 12.69%.

Institutional Investors Weigh In On Chemed

Hedge funds and other institutional investors have recently made changes to their positions in the company. Monetary Solutions Ltd bought a new stake in Chemed during the 4th quarter worth about $25,000. Los Angeles Capital Management LLC bought a new position in shares of Chemed in the 4th quarter valued at about $26,000. Smartleaf Asset Management LLC grew its position in shares of Chemed by 71.4% during the 3rd quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock worth $27,000 after buying an additional 25 shares during the period. BOK Financial Private Wealth Inc. bought a new stake in shares of Chemed during the fourth quarter worth approximately $27,000. Finally, Creekmur Asset Management LLC bought a new stake in shares of Chemed during the second quarter worth approximately $28,000. 95.85% of the stock is owned by institutional investors and hedge funds.

Key Chemed News

Here are the key news stories impacting Chemed this week:

• Positive Sentiment: Oppenheimer lowered its price target but kept an “outperform” rating (PT cut to $500), signaling some analysts still see multi‑quarter upside despite the recent miss. Oppenheimer PT/Rating
• Neutral Sentiment: RBC reaffirmed a “sector perform” rating and set a $422 target (down from $572), reflecting a more cautious stance but not a full downgrade; this indicates mixed analyst conviction. RBC note
• Neutral Sentiment: Chemed issued FY‑2026 EPS guidance of $23.25–$24.25 (roughly in line but slightly below consensus), and said ~55% of 2026 earnings are likely back‑half weighted as it executes transition initiatives — guidance tempers but does not eliminate investor concern. Earnings release / guidance
• Neutral Sentiment: Full Q4 earnings and conference-call transcripts were posted (Seeking Alpha, Yahoo, others); these provide management commentary on margin compression, VITAS trends and cash‑flow dynamics for investors doing deeper diligence. Earnings call transcript
• Negative Sentiment: Zacks highlights the headline: Q4 EPS and revenue missed consensus, margins contracted and the FY‑2026 EPS outlook came in below street expectations — the earnings shock was the primary catalyst for the sharp share drop. Zacks: Earnings & margins miss
• Negative Sentiment: Detailed quarter metrics (QuiverQuant) show revenue and EPS declines, steeper drops in operating cash flow and lower cash balances — these raise near‑term liquidity and execution risk concerns for investors. QuiverQuant: Financial details
• Negative Sentiment: Johnson Fistel announced an investigation into possible claims tied to Chemed executives — potential litigation risk can amplify selling pressure and valuation uncertainty. GlobeNewswire: Investigation notice
• Negative Sentiment: BofA cut Chemed to neutral after the Q4 miss — another sign of weakening analyst conviction that can pressure sentiment until evidence of margin/cash‑flow stabilization appears. MSN / BofA note

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.